ImmunoGen, Inc. provides earnings guidance for the year 2022. For the period, the company expects revenues between $75 million and $85 million.
1st Jan change | Capi. | |
---|---|---|
+34.74% | 52.85B | |
-7.64% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+11.60% | 26.16B | |
-19.94% | 19.9B | |
+38.91% | 13.18B | |
+30.46% | 12.24B | |
-3.40% | 11.79B |